Acyclovir
- Product NDC
- 70934-800
- 11-digit product format
- 709340800
- Labeler code
- 70934
- Product ID
- 70934-800_da6f0391-dc87-200e-e053-2995a90a0f39
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Acyclovir
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA075090
- Marketing category
- ANDA
- Marketing start
- 2020-10-22
- Marketing end
- 2024-04-30
- Substance
- ACYCLOVIR
- Active strength
- 200 mg/1
- Pharmacologic classes
- DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 70934-800-25 | 70934080025 | 25 CAPSULE in 1 BOTTLE, PLASTIC (70934-800-25) | 25 capsule | 2022-03-14 | 2023-10-31 | No | No | Current |
| 70934-800-30 | 70934080030 | 30 CAPSULE in 1 BOTTLE, PLASTIC (70934-800-30) | 30 capsule | 2020-10-22 | 0000-00-00 | No | No | Current |